Access, Representation, and Opportunity: A Toolkit
HOPA’s vision is that all individuals affected by cancer have a hematology/oncology pharmacist as an integral member of their care team. To help realize this vision, HOPA’s mission is to support pharmacy practitioners and promote and advance hematology/oncology pharmacy to optimize the care of individuals affected by cancer.
Resources Curated by Pharmacists for Pharmacists
Recognizing our role in addressing and dismantling systems of inequity, injustice, and exclusion in our healthcare systems, the DEI Task Force (2021-2022) and DEI Committee (2022-2023) developed this toolkit to provide every HOPA member the resources to increase awareness, and develop and instill people-first principles in each member’s personal and professional environment.
Today, the HOPA ARO Advisory Group manages the toolkit. We recognize each person’s journey is unique, but we hope that these resources will be invaluable in your personal and professional development.
For more information and to dive deeper into toolkit, click the category images below:
ARO Fundamentals
Learn more about the "roadmap" to core ARO principles and concepts with the help of this collection of informative articles, videos, podcasts, resources, and more.
Education and Training
Access informational literature, readings, checklists, and much more discussing ARO principles in today's educational and training programs, and the impact they can have now and for the future of healthcare.
Patient Care Resources
This toolkit section features informational resources, videos, literature, and more providing ARO education and support to healthcare providers as well as their patients.
ARO in the Workplace
Access resources, informational resources, engaging readings, and more about ARO in the workplace, why it's important to cultivate, and how one can bring its principles to their day-to-day work.
Research Disparities
Access tools, informational literature, resource guides and more that discuss and interrogate disparities in medical research and clinical trials, historical context, ways to move research forward for all in the future, and more.
